Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.440
+0.020 (1.41%)
At close: Jan 15, 2026, 4:00 PM EST
1.440
0.00 (0.00%)
Pre-market: Jan 16, 2026, 6:06 AM EST
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Autolus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $8.33, which forecasts a 478.47% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $10.
Price Target: $8.33 (+478.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +594.44% | Jan 12, 2026 |
| Needham | Needham | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +663.89% | Dec 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +594.44% | Dec 12, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +594.44% | Nov 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +594.44% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
78.17M
from 10.12M
Increased by 672.42%
Revenue Next Year
144.21M
from 78.17M
Increased by 84.48%
EPS This Year
-0.98
from -0.86
EPS Next Year
-0.78
from -0.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 90.8M | 188.3M | ||||
| Avg | 78.2M | 144.2M | ||||
| Low | 70.1M | 107.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 797.5% | 140.8% | ||||
| Avg | 672.4% | 84.5% | ||||
| Low | 592.4% | 37.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.87 | -0.53 | ||||
| Avg | -0.98 | -0.78 | ||||
| Low | -1.04 | -1.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.